Publications by authors named "Christophe Sajous"

Claim this Profile
P
Prolonged response to lenvatinib in a poorly differentiated thyroid carcinoma with leptomeningeal carcinomatosis.
Christophe Sajous, Helene Lasolle, Myriam Decaussin-Petrucci, Jonathan Lopez, Françoise Borson Chazot

Ann Endocrinol (Paris)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From hyperplasia to carcinoma: a molecular driven adrenal disease.
Elisa Dybal, Myriam Decaussin-Petrucci, Françoise Descotes, Gérald Raverot, Jean-Christophe Lifante, Christophe Sajous

Eur J Endocrinol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Borderlines and malignant phyllodes tumors of the breast: From the anatomopathological challenge to the standard of care].
Mathias Neron, Aurélie Maran Gonzalez, Carmen Llacer, Sébastien Carrere, Christophe Sajous

Bull Cancer· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Hélène Lasolle, Françoise Borson-Chazot, Thibault Gauduchon, Magalie Haissaguerre, Frédéric Illouz, Christophe Sajous

Bull Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal Nivolumab after Debulking Surgery and Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: A Phase I Study with Expansion Cohort.
Pauline Corbaux, Gilles Freyer, Olivier Glehen, Benoît You, Naoual Bakrin, Christophe Sajous

Clin Cancer Res· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory BRAF p.V600E-Mutated Differentiated Thyroid Cancer.
Sophie Leboulleux, Christine Do Cao, Slimane Zerdoud, Marie Attard, Claire Bournaud, Christophe Sajous

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to first line platinum-based chemotherapy in mismatch repair deficient (MMRd)/ microsatellite instability high (MSI-high) endometrial carcinoma.
Emeline Colomba, Jérôme Alexandre, Gwénaël Le Teuff, Catherine Genestie, Dahna Coupez, Christophe Sajous

Gynecol Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).
Anne-Sophie Belmont, Christophe Sajous, Amandine Bruyas, Sara Calattini, Stéphanie Cartalat

Cancers (Basel)· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma: What Are the Most Appropriate Combination Therapies?
Yann-Alexandre Vano, Sylvain Ladoire, Réza Elaidi, Slimane Dermeche, Jean-Christophe Eymard, Christophe Sajous

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
Denis Maillet, Nathalie Allioli, Julien Péron, Adriana Plesa, Myriam Decaussin-Petrucci, Christophe Sajous

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study.
Julien Péron, Tristan Dagonneau, Anne Conrad, Fanny Pineau, Sara Calattini, Christophe Sajous

Cancers (Basel)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RADTHYR: an open-label, single-arm, prospective multicenter phase II trial of Radium-223 for the treatment of bone metastases from radioactive iodine refractory differentiated thyroid cancer.
Désirée Deandreis, Aline Maillard, Slimane Zerdoud, Claire Bournaud, Lavinia Vija, Christophe Sajous

Eur J Nucl Med Mol Imaging· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives.
Romain Varnier, Christophe Sajous, Solène de Talhouet, Colette Smentek, Julien Péron

Cancers (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Front-Line Maintenance Therapy in Advanced Ovarian Cancer-Current Advances and Perspectives.
Thibaut Reverdy, Christophe Sajous, Julien Péron, Olivier Glehen, Naoual Bakrin

Cancers (Basel)· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical Margins and Adjuvant Therapies in Malignant Phyllodes Tumors of the Breast: A Multicenter Retrospective Study.
Mathias Neron, Christophe Sajous, Simon Thezenas, Sophie Piperno-Neumann, Fabien Reyal

Ann Surg Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7).
Olivier Colomban, Michel Tod, Julien Peron, Timothy J Perren, Alexandra Leary, Christophe Sajous

JNCI Cancer Spectr· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Metastasis Surgery and Alkylating-Agent-Based Chemotherapy on Outcomes of Metastatic Malignant Phyllodes Tumors: A Multicenter Retrospective Study.
Mathias Neron, Christophe Sajous, Simon Thezenas, Sophie Piperno-Neumann, Fabien Reyal

Ann Surg Oncol· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IFN-III is selectively produced by cDC1 and predicts good clinical outcome in breast cancer.
Margaux Hubert, Elisa Gobbini, Coline Couillault, Thien-Phong Vu Manh, Anne-Claire Doffin, Christophe Sajous

Sci Immunol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Immune checkpoints inhibitors: Recent data from ASCO's meeting 2017 and perspectives].
Maria Kfoury, Valentine Disdero, Cécilé Vicier, Olivia Le Saux, Paul Gougis, Christophe Sajous

Bull Cancer· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis